Scientists look to outliers in quest for cures

09/19/2013 | Reuters

Advances in genome sequencing technology are allowing researchers to study why some patients respond well to treatments that fail in others with the same disease. The research could lead to new uses for existing and abandoned compounds, researchers say. Projects are planned or underway at the National Cancer Institute, Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center and Dana-Farber Cancer Institute, among others.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL